共 50 条
- [1] EFFICACY OF BREXPIPRAZOLE ACROSS AGITATION BEHAVIORS IN ALZHEIMER'S DISEASE, INCLUDING IMPACT ON CAREGIVERS, ANALYZED USING THE NEUROPSYCHIATRIC INVENTORY: A POST HOC POOLED ANALYSIS OF RANDOMIZED, FIXED-DOSE, PLACEBO -CONTROLLED TRIALS AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2024, 32 (04): : S93 - S93
- [2] EFFICACY AND SAFETY OF BREXPIPRAZOLE IN PATIENTS WITH AGITATION ASSOCIATED WITH DEMENTIA DUE TO ALZHEIMER'S DISEASE ANALYZED BY PRESENCE OR ABSENCE OF BASELINE PSYCHOSIS: A POOLED ANALYSIS AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2024, 32 (04): : S94 - S94
- [5] EFFECTS OF BREXPIPRAZOLE ON SEVERITY OF AGITATION IN ALZHEIMER'S DEMENTIA: AN ANALYSIS OF CLINICAL GLOBAL IMPRESSION DATA FROM TWO, PHASE III FIXED-DOSE TRIALS AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2024, 58 : 179 - 179
- [6] Efficacy and Safety of Brexpiprazole for the Treatment of Agitation in Alzheimer's Dementia: Two 12-Week, Randomized, Double-Blind, Placebo-Controlled Trials AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2020, 28 (04): : 383 - 400
- [10] EFFICACY, SAFETY AND TOLERABILITY OF BREXPIPRAZOLE FOR THE TREATMENT OF AGITATION IN ALZHEIMER'S DEMENTIA: A 12-WEEK, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2023, 31 (03): : S99 - S100